Ricard Ferrer
Universitat Autònoma de Barcelona
ORCID: 0000-0002-4859-4747Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial”.
Bruno François, Marc Bourgeois, Apostolos Komnos, Ricard Ferrer, Galia Rahav +94 more
Laura E. Evans, Waleed Alhazzani, Mitchell M. Levy, Massimo Antonelli, Ricard Ferrer +71 more
Andrew Rhodes, Waleed Alhazzani, Massimo Antonelli, Craig M. Coopersmith, Craig French +55 more
Andrew Rhodes, Waleed Alhazzani, Massimo Antonelli, Craig M. Coopersmith, Craig French +55 more
Andrew Rhodes, Otavio T. Ranzani, Jorge I. Salluh, Joana Berger‐Estilita, Craig M. Coopersmith +57 more